Form 483

Medtronic Neuromodulation Form 483, 2019-10-17

FDA issued a Form 483 to Medtronic Neuromodulation on 2019-10-17 with 4 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health4 observations

Medtronic Neuromodulation · Minneapolis, United States · Issued October 17, 2019

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Oct 2019
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Joseph D Gong, Susan M Matthias

17 Oct 2019
21 CFR 820.30(c)

Design input - documentation

Cited by Joseph D Gong, Susan M Matthias

17 Oct 2019
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Joseph D Gong, Susan M Matthias

17 Oct 2019
21 CFR 820.30(c)

Design input - documentation

Cited by Joseph D Gong, Susan M Matthias

Inspected site

MNMedtronic NeuromodulationMinneapolis, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations2x
21 CFR 820.30(c)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere